| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT01645085 | Healthy Volunteers | Drug: MCC-based 13% drug loaded tablets|Drug: Mannitol-based 38% drug-loaded tablet|Drug: MCC-based 13% drug loaded tablets|Drug: Mannitol-based 38% drug-loaded tablet | AstraZeneca | Phase 1 | 2012-07-01 | 2013-03-18 |
| NCT01682408 | Pharmacokinetics | Drug: Fostamatinib - 1 x 150mg mannitol-based 38% drug-loaded tablet(orange reference)|Drug: Fostamatinib - 3 x 50mg microcrystalline cellulose-based 13% drug loaded tablets,(blue) fed|Drug: Fostamatinib - 1 x 150mg mannitol based 38% drug-loaded tablet (batch variant A)|Drug: Fostamatinib - 1 x 150mg mannitol based 38% drug loaded tablet (batch variant B)|Drug: Ranitidine | AstraZeneca | Phase 1 | 2012-09-01 | 2012-12-27 |
| NCT01598571 | Healthy | Drug: Fostamatinib|Drug: Fostamatinib | AstraZeneca | Phase 1 | 2012-05-01 | 2012-08-21 |
| NCT01222455 | Hepatic Impairment|Healthy Volunteers|Pharmacokinetics|Amount of R406 in Blood | Drug: Fostamatinib | AstraZeneca | Phase 1 | 2010-10-01 | 2011-07-05 |
| NCT01336218 | Rheumatoid Arthritis|Healthy Volunteers | Drug: fostamatinib|Drug: rifampicin | AstraZeneca | Phase 1 | 2011-04-01 | 2011-07-21 |
| NCT01197781 | Drug Drug Interactions|Healthy Volunteers | Drug: FOSTAMATIN|Drug: Verapamil | AstraZeneca | Phase 1 | 2010-09-01 | 2010-11-19 |
| NCT01245790 | Rheumatoid Arthritis|Renal Impairment | Drug: fostamatinib | AstraZeneca | Phase 1 | 2010-11-01 | 2011-06-15 |
| NCT01387308 | Healthy | Drug: Fostamatinib|Drug: Fostamatinib|Drug: Fostamatinib|Drug: Fostamatinib|Drug: Fostamatinib | AstraZeneca | Phase 1 | 2011-08-01 | 2011-10-27 |
| NCT01355354 | Healthy Volunteers|Rheumatoid Arthritis | Drug: Digoxin|Drug: Fostamatinib | AstraZeneca | Phase 1 | 2011-06-01 | 2011-10-05 |
| NCT01311622 | Rheumatoid Arthritis|Healthy Subjects | Drug: warfarin|Drug: fostamatinib | AstraZeneca | Phase 1 | 2011-03-01 | 2013-01-30 |
| NCT01208155 | Bioavailability|Pharmacokinetics | Drug: Fostamatinib|Drug: Fostamatinib|Drug: Fostamatinib|Drug: Fostamatinib | AstraZeneca | Phase 1 | 2010-09-01 | 2010-12-07 |
| NCT01725230 | Rheumatoid Arthritis | Drug: Fostamatinib|Drug: Rosuvastatin|Drug: Simvastatin | AstraZeneca | Phase 1 | 2012-11-01 | 2013-02-01 |
